Cargando…
RISPERIDONE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME : A CASE REPORT
A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response o...
Autores principales: | Venkatasubramanian, G., Yogananda, B.H., Gangadhar, B.N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956992/ https://www.ncbi.nlm.nih.gov/pubmed/21407918 |
Ejemplares similares
-
Risperidone-induced neuroleptic malignant syndrome: a case
report
por: Deng, Ling, et al.
Publicado: (2022) -
CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002) -
Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus
por: Arslankoylu, Ali Ertug, et al.
Publicado: (2011) -
Exceptionally high creatine kinase levels in risperidone-induced neuroleptic malignant syndrome: A case report
por: Ozaal, Siddiqa, et al.
Publicado: (2022) -
Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome?
por: Nikolaou, Kalliopi N., et al.
Publicado: (2015)